Citius Oncology (CTOR) vs Retension Pharmaceuticals (RTSN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 12, 2026.
Summary
Retension Pharmaceuticals is the larger company by market cap ($89.2 million vs $85.9 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | CTOR | RTSN |
|---|---|---|
| Share price | $0.8126 | $11.32 |
| Market cap | $85.94M | $89.22M |
| 1-day change | -3.24% | +7.50% |
| YTD return | -16.02% | — |
| 1-year return | -51.46% | — |
| EPS (TTM) | $-0.48 | $-2.61 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.25 | $11.79 |
| 52-week low | $0.491 | $9.66 |
| Distance from 52-week high | -63.88% | -3.99% |
| Analyst consensus | none | — |
| Avg. price target upside | +392.25% | — |
| Average volume | 100.94K | 789.20K |
| Shares outstanding | 105.76M | 7.88M |
| Employees | — | 12 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Citius Oncology
CTOR stock →Citius Oncology, Inc. focuses on the development and commercialization of targeted oncology therapies.
Health Care · Biotechnology: Pharmaceutical Preparations
About Retension Pharmaceuticals
RTSN stock →Retension Pharmaceuticals, Inc. operates as a clinical -stage biopharmaceutical company focused on developing medicines for the treatment of hypertension and other cardiovascular diseases.
Health Care · Biotechnology: Pharmaceutical Preparations · 12 employees
CTOR vs RTSN FAQ
Which is bigger, Citius Oncology or Retension Pharmaceuticals?
Retension Pharmaceuticals (RTSN) is larger, with a market capitalization of $89.22M compared with $85.94M for Citius Oncology (CTOR).
Are Citius Oncology and Retension Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.